title: [Diagnostics and therapy of heart failure].
abstract: Heart failure represents one of the most common diseases in the western world with an estimated prevalence of 0.4-2% in Europe. The frequency and incidence is very age-dependant and chronic cardiac insufficiency has a high stage-dependant mortality. Aging of the population and prolongation of the lives of cardiac patients has led to an increasing prevalence of heart failure. However, average survival remains poor after hospitalization for a first episode of heart failure. Diagnostics and therapy of heart failure are subject to constant change due to ongoing progress in research and new randomized controlled trials. This review will focus on new developments and current guidelines for diagnosis and treatment of heart failure. Findings on natriuretic peptides and echocardiography in patients with preserved ejection fraction will be presented and innovative therapeutic measures, such as ivabradine will be discussed. Besides new drug developments insight into device therapy, such as MitraClip® and operative approaches for heart failure will be presented.
authors: Universitätsklinik II für Innere Medizin, Paracelsus Medizinische Privatuniversität, Müllner Hauptstr. 38, A-5020, Salzburg, Österreich.
authors: R
authors: R
authors: Steinacher
authors: D
authors: D
authors: Rottlaender
authors: U C
authors: UC
authors: Hoppe
mesh_terms: D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004452:Echocardiography / Q000379:methods*; D006333:Heart Failure / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans
chemical_list: D002316:Cardiotonic Agents